Mae'r cynnwys hwn ar gael yn Saesneg yn unig.
Trosolwg
Cyhoeddiadau
2022
- Joshi, H. B. et al. 2022. Urinary stones and intervention quality of life (USIQoL): development and validation of a new core universal patient-reported outcome measure for urinary calculi. European Urology Focus 8(1), pp. 283-290. (10.1016/j.euf.2020.12.011)
2020
- Raja, A., Wood, F. and Joshi, H. B. 2020. The impact of urinary stone disease and their treatment on patients' quality of life: a qualitative study. Urolithiasis 48, pp. 227-234. (10.1007/s00240-019-01142-0)
2017
- George, J., Raja, A., Chun Hei Li, D. and Joshi, H. 2017. Fournier's gangrene: diagnosis and management aided by repeated clinical examination and ultrasound. BMJ Case Reports, article number: bcr2016217409. (10.1136/bcr-2016-217409)
2016
- Raja, A., Hekmati, Z. and Joshi, H. 2016. How do urinary calculi influence health-related quality of life and patient treatment preference: a systematic review. Journal of Endourology 30(7), pp. 727-743. (10.1089/end.2016.0110)
- Williams, N. A. et al. 2016. Evidence of nonuniformity in urothelium barrier function between the upper urinary tract and bladder. Journal of Urology 195(3), pp. 763-770. (10.1016/j.juro.2015.10.066)
2014
- Raja, A., O'Neill, C., Joshi, H. B. and Salek, M. 2014. Re: Development of an instrument to assess the health related quality of life of kidney stone formers: K. L. Penniston and S. Y. Nakada J Urol 2013;189:921–930 [letter]. The Journal of Urology 192(1), pp. 280-281. (10.1016/j.juro.2014.01.112)
- Williams, N. et al. 2014. An ex Vivo investigation into the transurothelial permeability and bladder wall distribution of the nonsteroidal anti-inflammatory Ketorolac. Molecular Pharmaceutics 11(3), pp. 673-682. (10.1021/mp400274z)